Top compounds associated with response to ARMCX5


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.052 0.1
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.057 0.1
mRNA BRD-K42260513 CTRPv2 pan-cancer AAC 0.086 0.1
mRNA masitinib CTRPv2 pan-cancer AAC 0.055 0.1
mRNA bafilomycin A1 CTRPv2 pan-cancer AAC -0.21 0.1
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.054 0.1
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.072 0.1
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC 0.072 0.1
mRNA clofarabine CTRPv2 pan-cancer AAC 0.044 0.1
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.053 0.1
Download CSV